IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS - ANVISA Registration 80134860250

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860250 and manufactured by manufacturer not specified. The registration is held by GRIFOLS BRASIL LTDA with validity until Jul 17, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including IMMUCOR, INC, MEDION DIAGNOSTICS GRIFOLS AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.